Age [years] |
63.3 (8.9) |
|
Men (N (%)) |
|
4 (11.4%) |
Women (N (%)) |
|
31 (88.6%) |
Glaucoma treatment [years] |
6.1 (6.3) |
|
Patients receiving systemic medications: |
2.3 (1.9) |
|
Beta blockers (N (%)) |
|
12 (34.3%) |
ACE inhibitors (N (%)) |
|
7 (20.0%) |
Angiotensin II inhibitors (N (%)) |
|
6 (17.1%) |
Diuretics (N (%)) |
|
6 (17.1%) |
Other drugs (N (%)) |
|
18 (51.4%) |
|
|
|
Systolic BP-baseline [mmHg] |
139.5 (15.0) |
|
Diastolic BP-baseline [mmHg] |
82.8 (7.1) |
|
Pulse rate-baseline |
69.3 (13.8) |
|
|
|
|
Systolic BP-Dorzolamide add-on [mmHg] |
136.1 (14.0) |
|
Diastolic BP-Dorzolamide add-on [mmHg] |
81.2 (8.0) |
|
Pulse rate-Dorzolamide add-on |
71.8 (9.0) |
|
|
|
|
Systolic BP-Timolol add-on [mmHg] |
137.6 (14.0) |
|
Diastolic BP-Timolol add-on [mmHg] |
80.7 (8.7) |
|
Pulse rate-Timolol add-on |
68.2 (13.7) |
|